IRE SINGLE ELECTRODE PROBE
Report
- Report Number
- 1319211-2010-00010
- Event Type
- Malfunction
- Date Received
- March 19, 2010
- Date of Event
- February 22, 2010
- Report Date
- March 17, 2010
- Manufacturer
- ANGIODYNAMICS, INC.
- Product Code
- OHJ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
LOT HISTORY RECORD REVIEW: THE COMPLAINT INFO WAS FORWARDED TO PRONET. PRONET REVIEWED THE POSSIBLE LOT HISTORY RECORDS AND FOUND NO VARIANCES RELATED TO THIS EVENT WERE OBSERVED. REVIEW OF RETURNED SAMPLE: THE COMPLAINT SAMPLE IS NOT AVAILABLE FOR EVAL. CONCLUSION: THE EXACT CAUSE OF THE COMPLAINT IS UNK. EPISODES OF ATRIAL FIBRILLATION MAY LAST A FEW HOURS OR SEVERAL DAYS. MOST PEOPLE WITH ATRIAL FIBRILLATION HAVE SOME STRUCTURAL ABNORMALITIES OF THE HEART RELATED TO SUCH CONDITIONS AS HEART DISEASE OR HIGH BLOOD PRESSURE. OTHER FACTORS THAT MAY CONTRIBUTE TO ATRIAL FIBRILLATION INCLUDE HEART VALVE DISORDER, HYPERTHYROIDISM OR HEAVY ALCOHOL CONSUMPTION. THIS TYPE OF COMPLAINT WILL CONTINUE TO BE MONITORED FOR TRENDS. NO FURTHER ACTION REQUIRED AT THIS TIME. FREQUENCY HAS INCREASED BUT THE SEVERITY OF THIS EVENT IS NOT GREATER THAN USUAL.
PT EXPERIENCED TACHYCARDIA WENT INTO ATRIAL FIBRILLATION DURING THE DELIVERY OF THE IRE FOR THE SECOND LESION LOCATED IN THE DOME OF THE LIVER. THE CLOSEST ACTIVE PORTION OF AN ELECTRODE WAS LESS THAN OR EQUAL TO 5MM FROM THE PERICARDIUM. ANESTHESIA PERFORMED MULTIPLE INTERVENTIONS TO CORRECT THE ARRHYTHMIA; BETA BLOCKER, LIDOCAINE, CORTIZOME, CARDIOAVERSION (20/50/70 JOULES). CARDIOAVERSION AT 70 JOULES RESOLVED THE ARRHYTHMIA. ANESTHESIA CHECKED FOR ELECTROLYTE ABNORMALITIES AND DID NOT FIND ANY. PT HAS NORMAL EKG RHYTHM AND RECOVERED FROM ANESTHESIA FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | IRE SINGLE ELECTRODE PROBE | IRE SINGLE ELECTRODE PROBE | OHJ | ANGIODYNAMICS, INC. | 00810709 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | Required Intervention |